Association of Cardiovascular Nursing & Allied Professions
Injectable treatments in CV patients
Increasingly, novel strategies in the form of injectable medicines are being developed and approved to reduce the risk of CVD events in patients at high risk of, or with established CVD. Despite the reductions in the mortality from cardiovascular disease (CVD), it remains a challenge with many suboptimal risk modification.
In this short survey, we aim to understand your views on the use of injectables to reduce the burden of CVD. We are interested in responses from all professions who are likely to initiate, support and/or monitor patients on these therapies (nurses, physicians and allied healthcare professionals).
This survey is being undertaken by the Europeans Association of Cardiovascular Nurses and Allied Professionals (ACNAP).
Thank you for your contribution